The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Immunol.
Sec. Comparative Immunology
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1495359
Porcine non-conventional B-1-like cells are a potent source of Streptococcus suis-binding IgM
Provisionally accepted- 1 Institute of Immunology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Lower Saxony, Germany
- 2 Department for Ruminants and Swine, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Lower Saxony, Germany
- 3 Institute of Bacteriology and Mycology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, Lower Saxony, Germany
Introduction: Streptococcus suis serotype (cps) 2 is an important bacterial pathogen in piglet nurseries and an emerging zoonotic agent without effective vaccines available. Immunoglobulin (Ig)M plays an essential role in host defense against S. suis. In mice, non-conventional B-1 cells are a major source of protective IgM against encapsulated bacterial pathogens, such as S. pneumoniae. Two IgM + CD21 - B-1-like cell subpopulations, distinguishable by CD11R1 expression, were described in pigs, but their properties and functions are poorly understood. This study aimed at a first characterization of the porcine early IgM B cell response against S. suis cps 2.We analyzed the same healthy pigs, naturally colonized by different S. suis serotypes, including cps 2, at four and eight weeks of age serologically and determined the frequency of different peripheral B cell subpopulations by flow cytometry. Furthermore, we isolated conventional IgM + CD21 + B-2 cells as well as non-conventional B-1-like cell subpopulations from peripheral blood of eight-weeks-old pigs to evaluate their potential of IgM secretion in response to innate and adaptive stimuli in vitro.Results: Between the fourth and eighth week of life, a characteristic increase of S. suis cps 2-binding serum IgM antibodies, restricting bacterial growth, was observed. Moreover, we show for the first time that the significant increase of anti-S. suis serum IgM is associated with a relative increase of peripheral non-conventional IgM + CD21 -B-1-like cells in vivo, particularly of the IgM + CD21 -CD11R1 - subpopulation. Noteworthy, sorted IgM + CD21 -CD11R1 -B-1-like cells from eight-weeks-old pigs spontaneously secreted IgM in vitro. In addition, both non-conventional IgM + CD21 -B cell subpopulations, in contrast to conventional IgM + CD21 + B-2 cells, produced anti-S. suis IgM upon tolllike receptor (TLR) stimulation underlining their innate-like characteristics. We furthermore observed that both B-1-like subpopulations secrete S. suis cps 2-binding IgM upon stimulation with T cellassociated factors with highest amounts in IgM + CD21 -CD11R1 -B-1-like cells even exceeding anti-S. suis IgM levels produced by B-2 cells.Porcine non-conventional B-1-like cells are a potent source of S. suis-binding IgM indicating a role in immunity during a critical phase of piglet rearing.
Keywords: Streptococcus suis, IgM, pig, Swine, non-conventional B cells, innate B-1 cells, B-2 cells, cell culture
Received: 12 Sep 2024; Accepted: 28 Oct 2024.
Copyright: © 2024 Seidel, Kauffold, Protschka, Baums, Alber and Eschke. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Maria Eschke, Institute of Immunology, Faculty of Veterinary Medicine, Leipzig University, Leipzig, 04103, Lower Saxony, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.